Insider Trading History of Lai Goldman Myla

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Lai Goldman Myla since 2005. This trader's CIK number is 1168581. At the time of last reporting, Lai Goldman Myla was the Officer of Akoya Biosciences, Inc.. (stock ticker symbol AKYA). Also see all insider trading activities at Akoya Biosciences, Inc..

Note that in the past LAI GOLDMAN MYLA also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Sequenom Inc (SQNM) by Lai Goldman Myla

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2012 SQNM 4,000 $18,376 0 $0 0 $0

Yearly summary of insider trading at Akoya Biosciences, Inc. (AKYA) by Lai Goldman Myla

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 AKYA 20,000 $100,000 0 $0 0 $0

Yearly summary of insider trading at Laboratory Corp Of America Holdings (LH) by Lai Goldman Myla

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 LH 0 $0 87,882 $6,854,285 50,400 $1,965,600
2007 LH 0 $0 1,556 $113,830 0 $0
2006 LH 0 $0 152,869 $8,854,436 146,200 $5,786,187
2005 LH 0 $0 7,401 $339,010 0 $0


Insider trading activities at 3 companies by Lai Goldman Myla:

1. Sequenom Inc (SQNM)

2. Akoya Biosciences, Inc. (AKYA)

3. Laboratory Corp Of America Holdings (LH)

Table 1. Insider trading of Sequenom Inc (SQNM) by Lai Goldman Myla

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2012-11-29 SQNM Buy 2,000 4.62 9,238
2012-11-28 SQNM Buy 2,000 4.57 9,138

Table 2. Insider trading of Akoya Biosciences, Inc. (AKYA) by Lai Goldman Myla

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-06-12 AKYA Buy 20,000 5.00 100,000

Table 3. Insider trading of Laboratory Corp Of America Holdings (LH) by Lai Goldman Myla

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-03-26 LH Sale 3,400 72.79 247,475
2008-03-26 LH Sale 9,700 73.49 712,853
2008-03-26 LH Sale 11,373 73.11 831,491
2008-03-03 LH Sale 1,611 77.25 124,449
2008-02-25 LH Sale 1,611 79.23 127,642
2008-02-20 LH Sale 1,611 79.65 128,309
2008-02-14 LH Sale 5,465 79.38 433,828
2008-02-14 LH Sale 102 79.16 8,074
2008-02-14 LH Sale 2,609 79.79 208,164
2008-02-13 LH Option Ex 6,500 39.00 253,500
2008-02-12 LH Option Ex 10,300 39.00 401,700
2008-02-13 LH Sale 6,500 80.00 520,000
2008-02-12 LH Sale 10,300 80.00 824,000
2008-02-13 LH Option Ex 6,500 39.00 253,500
2008-02-13 LH Sale 6,500 80.00 520,000
2008-02-12 LH Sale 10,300 80.00 824,000
2008-02-13 LH Option Ex 6,500 39.00 253,500
2008-02-12 LH Option Ex 10,300 39.00 401,700
2008-02-13 LH Sale 6,500 80.00 520,000
2008-02-12 LH Sale 10,300 80.00 824,000
2008-02-12 LH Option Ex 10,300 39.00 401,700
2007-02-05 LH Sale 1,556 73.16 113,830
2006-07-12 LH Sale 10,000 63.00 630,000
2006-07-12 LH Option Ex 10,000 47.89 478,900
2006-05-17 LH Option Ex 49,719 43.53 2,164,268
2006-05-17 LH Sale 49,719 60.14 2,990,100
2006-04-18 LH Sale 681 60.00 40,860
2006-04-18 LH Option Ex 681 43.53 29,643
2006-03-01 LH Sale 1,611 57.95 93,365
2006-02-21 LH Sale 9,832 57.97 569,990
2006-02-21 LH Sale 4,795 58.30 279,562
2006-02-21 LH Option Ex 16,800 24.46 410,928
2006-02-21 LH Sale 2,173 57.75 125,497
2006-02-17 LH Sale 2,104 58.06 122,154
2006-02-17 LH Option Ex 16,800 39.00 655,200
2006-02-17 LH Sale 14,696 58.33 857,247
2006-01-10 LH Sale 37,046 55.00 2,037,530
2006-01-10 LH Option Ex 37,046 39.17 1,451,091
2006-01-09 LH Option Ex 4,398 39.34 173,017
2006-01-09 LH Sale 9,456 54.62 516,477
2006-01-06 LH Option Ex 4,385 39.34 172,505
2006-01-06 LH Sale 4,385 55.02 241,249
2006-01-05 LH Option Ex 6,371 39.34 250,635
2006-01-05 LH Sale 6,371 55.00 350,405
2005-03-15 LH Sale 7,401 45.81 339,010

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lai Goldman Myla (Officer of Akoya Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.